Advertisement

Topics

Citoxlab acquires specialist CRO in drug transporter research and drug-drug interactions

07:55 EDT 14 Mar 2018 | EPM Magazine

Citoxlab Group, a non-clinical contract research organisation (CRO), has entered into a definitive agreement to acquire a CRO that specialises in drug transporter studies and the assessment of drug-drug interactions (DDI), Solvo Biotechnology.

Original Article: Citoxlab acquires specialist CRO in drug transporter research and drug-drug interactions

NEXT ARTICLE

More From BioPortfolio on "Citoxlab acquires specialist CRO in drug transporter research and drug-drug interactions"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...